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CHAPTER 1 
INTRODUCTION 
In the research literature pertaining to cancer rehabilitation, delineation is often 
made between “cancer patient” and “cancer survivor”. The term “cancer patient” 
typically refers to an individual undergoing treatment for active cancer, while “cancer 
survivor” refers to someone who has been through cancer treatment and is either in 
remission or is living with a reduced form of their original cancer. In recent years, there 
has been a concerted effort among cancer rehabilitation specialists to eliminate this 
delineation. For the purposes of this paper, a cancer survivor will be defined as “any 
individual that has been diagnosed with cancer, from the time of discovery and for the 
balance of life”, as suggested by the National Coalition for Cancer Survivorship.  
There is both anecdotal and empirical research evidence to indicate that many 
cancer patients who receive chemotherapy find the variety and unpredictability of 
chemotherapy-related side-effects difficult to cope with (Cohn, 1982; Tierney, Taylor & 
Closs 1989). Up to 80% of cancer survivors treated with chemotherapy experience 
fatigue and this fatigue has a greater negative impact on survivors’ activities of daily 
living (ADL) and quality of life (QOL) than other cancer-related symptoms, such as pain, 
depression, and nausea (Hofman et al., 2007). A decreased capacity to perform ADL  
(walking up and down stairs, getting up from a chair, lifting objects from the 
floor/overhead, and walking for short distances) is one of the most common side-effects 
of chemotherapy (Curt et al., 2000; Dimeo, Stieglitz et al., 1997; Given, Given, & 
Stommel, 1994; Irvine, Vincent, Graydon, & Bubela, 1998; Lehman et al., 1978; 
Messias, Yeager, Dibble, & Dodd, 1997; Mustian et al. 2008; Schwartz, 1999; Stafford & 
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Cyr, 1997). Decreases in ADL performance can be a major component of an overall 
decrement in quality of life for the cancer survivor (Courneya & Friedenreich, 1999; 
Dimeo, 2001; Ferrell, Grant, Dean, Funk, & Ly, 1996; Lehman et al., 1978).  
Participants in the investigation conducted by Irvine et al. (1998) indicated that 
their ability to complete functional activities was negatively altered by 20.1% over the 
course of treatment (mean age 60, wide variety of cancers). Another study reported that a 
majority of their participants (mean age 52, wide variety of cancers) experienced a 
significant decline in their ability to perform daily activities and noted that many of these 
individuals reduced their hours of employment or took leave of their position entirely 
(Messias et al., 1997). Stafford and Cyr (1997) reported that 48% of their cancer subject 
group (mean age 75, wide variety of cancers) experienced difficulty with at least one 
ADL during their treatment. A survey of a large cohort of survivors of a wide variety of 
cancers (4,878 Participants, age range: 18-88 years) determined that individuals with a 
cancer history were 30% more likely to have at least one functional limitation and 11% 
more likely to be unable to work because of their health (Hewitt, Rowland, & Yancik, 
2003). Similar data were reported by Ness, Wall, Oakes, Robison, and Gurney (2005) 
with physical performance limitations and participation restrictions reported to be 32 and 
18 percent more likely in cancer survivors than in individuals with no cancer history. In 
another study conducted by Mustian et al. (2008), 553 of 753 of cancer survivors who 
were receiving chemotherapy treatment reported that cancer related fatigue interfered 
with their activities of daily living. A similar study reported fatigue and ADL dependence 
in 81% of older cancer survivors (Luciani et al., 2008). 
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Chemotherapy drugs are suspected as being among the most neurotoxic of the 
cytotoxic agents (Wujcik, 1992). The chemotherapeutic agents most often associated with 
chemotherapy-induced peripheral neuropathy are platinum compounds, taxanes, vinca 
alkaloids, thalidomide, and bortezomib (Park et al., 2008; Visovsky, Collins, Abbott, 
Aschenbrenner, & Hart, 2007). These neurotoxic chemotherapy agents inactivate the 
components required to maintain the metabolic needs of the axon resulting in axonal 
degeneration. Peripheral neuropathy occurs as the end result of peripheral, motor, 
sensory, and autonomic neuron damage. There are both motor (muscle weakness and 
atrophy) and sensory signs of peripheral neuropathy (loss of proprioception, ataxia, loss 
of balance, and a decrease in vibration sensation) (Visovsky, 2003).  
 The motor and sensory deficits related to chemotherapy induced peripheral 
neuropathy contribute to balance loss that can impact functional performance in a 
negative manner (Park et al., 2008). The ability to sustain balance is heavily involved in 
the performance of many ADL and is a major factor in the maintenance of independent 
living (Judge, 2003; Kolbe-Alexander, Lambert, & Charlton, 2006; Powell, Carnegie, & 
Burke, 2006). Cancer survivors have been reported in the past to frequently have 
difficulties with dizziness and balance that are the result of their treatments (Dodd, 1987). 
This data is outdated and relies primarily on anecdotal accounts. Furthermore, these 
accounts have only be substantiated in studies of cancer survivors with cerebral tumors 
(Syczewska, Dembowska-Baginska, Perek-Polnik, Kalinowska, & Perek, 2008) or those 
undergoing treatments that elicit an inordinate loss of muscle mass (Bylow et al., 2008). 
These studies target specific cancer survivor groups and severely limit the ability to 
generalize to the entire population of cancer survivors. Other studies have focused on fine 
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motor movements rather than the gross motor movements involved in the ADL 
mentioned above. Despite continued evidence of balance issues from anecdotal accounts, 
little attention has been focused on balance testing in cancer survivors who have 
undergone chemotherapy) (Visovsky et al., 2007). 
 
Statement of Purpose 
The purpose of this research was to assess balance performance, ADL 
performance, and quality of life in cancer survivors who are undergoing or have 
undergone chemotherapy treatment within the past two years and to compare this data to 
the balance performance, ADL performance, and quality of life of age and physical 
activity level matched apparently healthy controls.  
 
Hypotheses 
It was hypothesized that:  
a.  cancer survivors who have undergone chemotherapy treatment will have  
  significantly poorer balance performance when compared to age-matched  
  apparently healthy controls.  
b.  balance performance will correlate with ADL performance, particularly in  
  cancer  survivors who have undergone treatment. 
c.          QOL will correlate with balance and ADL performance, particularly in 
cancer survivors who have undergone treatment. 
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CHAPTER 2 
METHODS 
Participants 
 Participants in this study were 19 male and female adults between the ages of 35 
and 70 years (most prevalent age range for cancer diagnosis). Nine of these participants 
were individuals diagnosed with cancer who received chemotherapy treatment within the 
last 2 years (C: 57±6 years; 7 females and 2 males). The average time from last 
chemotherapy treatment for C was 8.4 months. The remaining 10 participants were age-
matched, apparently healthy controls (H: 54±4 years; 6 females and 4 males). All 
participants were free of any major disease at the time of study participation (including 
vestibular disease).   
Participants in group C were recruited via fliers posted in the oncology offices in 
Southern Illinois. Participants in group H were recruited via flyers posted on the Southern 
Illinois University Carbondale (SIUC) campus. Upon initial contact, the researchers 
evaluated the participants suitability for the study based on the aforementioned medical 
criteria.   
Data Collection Procedures and Instruments 
Once participants were deemed suitable for study inclusion, they were mailed a 
medical history (see appendix C), a cancer treatment history (see appendix D), a quality 
of life questionnaire (Ferrans and Powers Quality of Life Index – Cancer Version III , 
see appendix A) (Ferrans, 1990), a physical activity level questionnaire (Baecke Self-
Administered Habitual Physical Activity Questionnaire, see appendix B) (Baecke, 
Burema, & Frijters, 1982), and were scheduled for testing. The medical and cancer 
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histories were used to evaluate the participants’ readiness for participation. On the testing 
day, the participants reported to Davies Hall (SIUC campus), returned all completed 
paperwork, and signed an informed consent approved by the SIUC Human Subjects 
Committee. Following these initial check-in procedures, participants completed the 
following tests under the supervision of the researchers. For all of the tests, only one trial 
was necessary and no familiarization trials were required.   
Balance 
Balance was tested using the AccuSwayPLUS® platform (AMTI) (Manor & Li, 
2009). The Accusway System consists of a portable balance platform. It measures the 
three forces (Fx, Fy, Fz) and three moments (Mx, My, Mz) involved in balance. For this 
study, balance trainer software was used for data acquisition and analysis. Each 
participant was asked to take a barefooted, double-legged stance on the platform with 
arms at side, heels 5 cm apart and heels abducted 10 degrees. The outlines of both feet 
were marked with a marker. After leaving the platform, the individual's base of support 
was entered in the computer using the pointer wand. Participant was then asked to step on 
the platform again with arms at side.  Participants performed 30 seconds of the eyes open 
closed base protocol. A member of the research team spotted each subject throughout the 
test to ensure that the chance of an accidental fall was minimized. The center of pressure 
average velocity (V; cm/s2) and center of pressure area (i.e., the area of a confidence 
ellipse enclosing 95% of the center-of-pressure trajectory) (A; cm2) were analyzed by the 
balance platform (Manor & Li, 2009).   
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Stair Climb and Descent 
Each subject’s ability to climb and descend stairs was evaluated using the stair 
climb and descent test (Malmberg et al., 2002; Salen, Spangfort, Nygren, & Nordemar, 
1994). The subject walked up and down a standard flight of stairs (12 steps, step rise: 7 
in., step run: 11 in.) three times at a self-selected pace, using a handrail for support if 
necessary. A stopwatch was started at the moment the first step was contacted during the 
initial ascent and stopped at the moment both of the subject’s feet were in contact with 
the “landing” area at the end of the 3rd descent. The ascent/descent performance time 
served as the primary variable for the evaluation of stair climbing ability. A member of 
the research team spotted each subject throughout the test to ensure that the chance of an 
accidental fall was minimized. The stair climb and descent test was found to have 
reliability rating of at least 0.70 (Salen et al., 1994). In addition the test has been shown 
to be highly feasible with less than 5% of 1133 subjects excluded from participation in 
the test (Malmberg et al., 2002).  
Sit to Stand 
The sit-to-stand test is a test of lower body extremity muscle strength and was 
used to evaluate each subject’s ability to get into and out of a chair (Csuka & McCarty, 
1985; Headley et al., 2002; Newcomer, Krag, & Mahowalk, 1993; Painter et al., 1999; 
Schicht, Camaiene, & Owen, 2001). The subject sat in a standard straight back, padded 
chair (seat height: 18.5 in.; seat depth: 18.1 in.) with arms folded across the chest (unless 
arm assistance was needed – “no arms” was encouraged). Following instructions on 
proper form and 1-2 practice trials, the subject stood up and sat down 10 times as quickly 
as possible. A stopwatch was started as soon as the subject began the initial “stand” and 
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was stopped when the subject sat down following the 10th repetition. The time that it took 
to complete the ten repetitions was used as the primary variable for the evaluation of the 
subject’s ability to get into and out of a chair. In order to ensure that the chance of an 
accidental fall was minimized, each subject was spotted throughout the test by a member 
of the research team. The sit-to-stand test has shown a test-retest reliability rating of 0.88 
(Newcomer, et al., 1993) and coefficient of variation of 6.8% (Czuka & McCarty, 1985).  
Lift and Carry 
The ability of each subject to pick up an object from the floor and carry it a short 
distance was evaluated via a lift and carry task. (Ettinger et al., 1997; Rejeski et al., 1995; 
Sevick et al., 2000). Using the protocol of Rejeski et al., the subject lifted a 13.5 by 13.5 
inch crate containing a 10-pound weight (total weight: 11.5 lb) from the floor to waist 
level, carried it at waist level for twenty feet (90° angle between upper and lower arm), 
set it on a shelf 51.5 inches high, picked up the crate again, carried it at waist level for 
twenty feet (90° angle between upper and lower arm), and safely set it back on the floor 
at the original starting point. A stopwatch was started on the subject’s first movement and 
was stopped when the weighted crate was set safely on the floor following the fifth 
repetition. The time required to complete the task was recorded and used as the research 
variable by which the subject’s ability to lift and carry an object was evaluated. Subjects 
were monitored to insure that proper lifting technique was utilized (bend at the knees, 
spine in neutral position; feet shoulder width apart, maintenance of balance). Subjects 
were spotted by a member of the research team throughout the test to ensure that the 
chance of an accidental injury was minimized. This lift and carry task has earned a 
reliability rating of 0.92 (Rejeski et al., 1995). 
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Data analysis procedures 
Means and standard deviations were calculated for all variables for both groups.  
The investigation utilized independent t-tests in order to determine if statistically 
significant differences exist between the study group mean values on all variables.  
Pearson correlation was done to determine the correlation of balance performance with 
ADL performance and quality of life. Alpha level was set at .05.    
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CHAPTER 3 
RESULTS 
As stated earlier, C and H were well-matched for age, C (M = 57, SD = 6) and H 
(M = 54, SD = 4), p = .321. Both groups were also well-matched at physical activity 
level, C (M = 36.2, SD = 2) and H (M = 38.1, SD = 4). p = .456. C demonstrated 
statistically significantly greater center of pressure area (A; cm2), C (M = 1.2, SD = .4) 
vs. H (M=.8, SD = .2), p = .046. While not statistically significant, C demonstrated 
greater center of pressure average velocity (V; cm/s2), C (M = .93, SD = .3) vs. H (M= 
.72, SD = .1), p = .078. H showed significantly higher quality of life than C, H (M = 5.3, 
SD = 0.32) vs. C (M = 4.8, SD = .55), p = .01). C showed reduced activities of daily 
living performance (varying level of significance) as indicated by 1) Slower timed stair 
climb and descent test performance as compared to H, C (M = 43.2, SD = 3.3 vs. H (M = 
32.9, SD = 4.5), p = .025.  2) Slower timed sit to stand test performance in C as compared 
to H, C (M = 32.7, SD = 8.1) vs. H (M = 25.3, SD = 2.2), p = .048.  3) Slower timed lift 
and carry performance as compared to H, C (M = 76.4, SD = 16.5) vs. H (M = 72.9, SD = 
11.3), p = .153. A strong correlation (Rubin, 2009; Sheskin, 2004) existed between A and 
stair climb/descent (r = .79), while moderate correlations (Rubin, 2009; Sheskin, 2004) 
existed between: A and sit to stand time (r = .59); V and stair/climb descent time (r = 
.52). Moderate correlations existed between A and QOL (r = .42), as well as lift and carry 
and QOL (.39).  See Table 1 and Table 2 for a visual depiction of the results. 
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Table 1 
Tests’ Results With p-values 
TESTS 
 
C 
 
H p-value 
STANDING BALANCE 
(Accusway Balance Platform®) 
   
Eyes open closed base - V; cm/s2 .93±.3 .72±.1 
 
. 078 
 
Eyes open closed base -A; cm2 1.2±.4 
 
.8±.2 
 
.046 
 
QUALITY OF LIFE 
(Ferrans and Powers – Likert Scale) 
4.8 ± .55 
 
5.3 ± 0.32 
 
.01 
 
ACTIVITIES OF DAILY LIVING    
Sit to stand 
(Seconds to complete 10 cycles) 
32.7±8.1 25.3±2.2 
 
. 048 
 
Stair climb/descent 
(Seconds to complete 3 cycles) 
43.2±3.3 
 
32.9±4.5 .025 
 
Lift and carry 
(Seconds to complete 5 cycles) 
76.4±16.5 72.9±11.3 
 
. 153 
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Table 2 
Cross-tabulation of Pearson Correlation Coefficients of A, V, ADL, and QOL 
 Sit to stand Stair climb/descent Lift and carry 
A .59 .79                    -- 
V -- .52 -- 
           QOL  -- -- .39 
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CHAPTER 4 
DISCUSSION 
The ability to sustain balance is involved in the performance of most ADL (Judge, 
2003; Kolbe-Alexander, Lambert, & Charlton, 2006; Powell, Carnegie, & Burke, 2006) 
and decreases in ADL performance can be a major component of an overall decrement in 
quality of life for the cancer survivor (Courneya & Friedenreich, 1999; Dimeo, 2001; 
Ferrell, Grant, Dean, Funk, & Ly, 1996; Lehman et al., 1978). The results of this study 
show that QOL was reduced along with ADL and balance performance in participants 
who had undergone chemotherapy. Although the results for center of pressure average 
velocity and the lift and carry test did not have statistically significant p- values, the 
results still indicate a trend toward better balance and activities of daily living 
performance in the healthy group based on group means. This study suggests a link 
between cancer treatment, balance, activities of daily living performance, and overall 
quality of life. The results are consistent with the hypotheses, cancer survivors showed 
significantly poorer balance performance when compared to age-matched apparently 
healthy controls. In addition, Balance performance correlated with ADL performance and 
QOL correlated with balance and ADL performance in cancer survivors. 
There were some potential limitations in this study. First, the mean age of group C 
was slightly higher than the mean age of Group H and this might have affected the 
results.  A recent study suggests that aging affects the balance performance year by year 
(Aslan, Cavlak, Yagci, & Akdag, 2008).  Another study has shown that balance, strength, 
gait and activity performance measures declined significantly with increasing age (Haber, 
Erbas, Hill, & Wark, 2008). With aging, a lower capacity for neuromuscular response in 
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controlling postural sway leads to  impaired balance with a decrease in speed of postural 
adjustments and event detection (Izquierdo, Aguado, Gonzalez, Lopez, Hakkinen, 1999). 
The slight age difference may have exacerbated the group differences beyond the effect 
of chemotherapy.  
Second, the male female ratio was different in both groups, with more female 
participants in group C as compared to group H. Studies have shown that women 
experience greater disability than men of the same age across a wide range of functional 
measures, including both basic ADL such as bathing and dressing, and instrumental 
ADL, such as housework and shopping (Newman, & Brach, 2001; Leveille, Resnick, & 
Balfour, 2000). Another study confirms gender differences in functional limitation onset 
and that males have better balance performance in comparison to females (Aslan, Cavlak, 
Yagci, & Akdag, 2007). A study conducted by Lee, Simmonds, Wang, & Novy (2003) 
showed that men outperformed women on all the activities measured in the study (i.e., 
repeated reach-ups, forward reach, 50-ft walk, and distance walked in 6 minutes). The 
reasons for these differences are not fully understood; however, the fact that group C 
contained a slightly higher percentage of females may have contributed to the fact that 
group C performance was diminished compared to group H.  
Third, all the participants in group C were involved on at least a limited basis in 
an aerobic and strength training exercise program either during or after the treatment and 
therefore, does not likely represent the typical cancer survivor who is more sedentary. 
Previous studies have shown that participating in exercise program can improve balance 
in older people (Barnett, Smith, Lord, Williams, & Baumand, 2003; Liu-Ambrose, Khan, 
Eng, Lord, & McKay, 2004). Despite the fact that there were no significant differences in 
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measured physical activity level between the groups, the fact that group C was likely 
more active than the typically cancer survivor may have diminished the potential for 
differences between the groups.   
Finally, the small sample size in the study limits the ability to generalize the 
results to the entire population of cancer survivors. The larger the sample size, the more a 
sample will represent the entire population. Future studies that examine this topic should 
target greater participant numbers.   
 This study underscores the need for exercise programs that target the functional 
needs of cancer survivors. Oncologists are often unsure of the appropriate 
recommendations for exercise when their patients inquire. Although future investigations 
are needed to further evaluate the effect of exercise on balance performance in 
individuals receiving chemotherapy, the findings of this research can improve the 
knowledge base of oncologists in this area and increases the frequency and urgency of 
recommendations to their patients to participate in regular exercise before, during, and 
after treatment. Involving cancer survivors in structured exercise prior to, during, and 
after their treatment can help them maintain a higher level of quality of life throughout 
their cancer experience. This could translate not only to an improvement in balance and 
ADL performance, but may also translate to higher levels of self esteem and self efficacy, 
reductions in depression and anxiety, and reduction in physician visits, home-nurse 
support, and overall health-care costs.   
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APPENDIX A 
 
Date: _________        Subject #: __________ 
 
Ferrans and Powers 
QUALITY OF LIFE INDEX© 
CANCER VERSION – III 
 
Part 1. For each of the following, please choose the answer that best describes how satisfied you are with that area of 
your life. Please mark your answer by circling the number. There are no right or wrong answers. 
How satisfied are you with:           V
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1. Your health?     1 2 3 4 5 6 
2. Your health care?    1 2 3 4 5 6 
3. The amount of pain that you have?   1 2 3 4 5 6 
4. The amount of energy you have for everyday activities? 1 2 3 4 5 6 
5. Your ability to take care of yourself without help?  1 2 3 4 5 6 
6. The amount of control you have over your life?  1 2 3 4 5 6 
7. Your chances of living as long as you would like? 1 2 3 4 5 6 
8. Your family’s health?    1 2 3 4 5 6 
9. Your children?     1 2 3 4 5 6 
10. Your family’s happiness?    1 2 3 4 5 6 
11. Your sex life?     1 2 3 4 5 6 
12. Your spouse, lover, or partner?   1 2 3 4 5 6 
13. Your friends?     1 2 3 4 5 6 
14. The emotional support you get from your family?  1 2 3 4 5 6 
15. The emotional support you get from people other family? 1 2 3 4 5 6 
16. Your ability to take care of family responsibilities? 1 2 3 4 5 6 
17. How useful are you to others?   1 2 3 4 5 6 
18. The amount of worries in your life?   1 2 3 4 5 6 
19. Your neighborhood?    1 2 3 4 5 6 
20. Your home, apartment, or place where you live?  1 2 3 4 5 6 
21. Your job (if employed)?    1 2 3 4 5 6 
22. Not having a job (If unemployed, retired, or disabled)? 1 2 3 4 5 6 
23. Your education?    1 2 3 4 5 6 
24. How well you can take care of your financial needs? 1 2 3 4 5 6 
25. The things you do for fun?    1 2 3 4 5 6 
26. Your chances for a happy future?   1 2 3 4 5 6 
27. Your peace of mind?    1 2 3 4 5 6 
28. Your faith in your religion?    1 2 3 4 5 6 
29. Your achievement of personal goals?   1 2 3 4 5 6 
30. Your happiness in general?   1 2 3 4 5 6 
31. Your life in general?    1 2 3 4 5 6 
32. Your personal appearance?   1 2 3 4 5 6 
33. Yourself in general?    1 2 3 4 5 6 
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Part 2. For each of the following, please choose the answer that best describes how important that area of 
your life is to you. Please mark your answer by circling the number. There are no right or wrong answers. 
 
How important to you is:                             V
er
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1. Your health?      1 2 3 4 5 6 
2. Your health care?    1 2 3 4 5 6 
3. Having no pain?     1 2 3 4 5 6 
4. Having enough energy for everyday activities?  1 2 3 4 5 6 
5. Taking care of yourself without help?   1 2 3 4 5 6 
6. Having control over your life?   1 2 3 4 5 6 
7. Living as long as you would like?   1 2 3 4 5 6 
8. Your family’s health?    1 2 3 4 5 6 
9. Your children?     1 2 3 4 5 6 
10. Your friends’s health?    1 2 3 4 5 6 
11. Your sex life?     1 2 3 4 5 6 
12. Your spouse, lover, or partner?   1 2 3 4 5 6 
13. Your friends?     1 2 3 4 5 6 
14. The emotional support you get from your family?  1 2 3 4 5 6 
15. The emotional support you get from people other than family? 1 2 3 4 5 6 
16. Taking care of family responsibilities?   1 2 3 4 5 6 
17. Being useful to others?    1 2 3 4 5 6 
18. Having no worries?    1 2 3 4 5 6 
19. Your neighborhood?    1 2 3 4 5 6 
20. Your home, apartment, or place where you live?  1 2 3 4 5 6 
21. Your job (if employed)?    1 2 3 4 5 6 
22. Having a job (if unemployed, retired, or disabled)?  1 2 3 4 5 6 
23. Your education?     1 2 3 4 5 6 
24. Being able to take care of your financial needs?  1 2 3 4 5 6 
25. Doing things for fun?    1 2 3 4 5 6 
26. Having a happy future?    1 2 3 4 5 6 
27. Peace of mind?     1 2 3 4 5 6 
28. Your faith in your religion?    1 2 3 4 5 6 
29. Achieving your personal goals?   1 2 3 4 5 6 
30. Your happiness in general?    1 2 3 4 5 6 
31. Being satisfied with life?    1 2 3 4 5 6 
32. Your personal appearance?    1 2 3 4 5 6 
33. Yourself as a member of society?   1 2 3 4 5 6 
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APPENDIX B 
 
Date: _________       Subject #: __________ 
 
Baecke Self-Administered Habitual Physical Activity Questionnaire: 
 
For each item, circle the response that best pertains to your physical activity level over the course of the 
past few weeks. If you are retired, answer the “work-related” questions based on any time in your daily 
routine that you would not consider “leisure time” (yardwork, gardening, housework, volunteer work, 
babysitting, etc.) 
 
A)   At work, I sit 
 
1) Always     2) Often         3)  Sometimes        4)  Seldom           5) Never 
 
 
B) At work, I stand 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
C)  At work, I walk 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
D) At work, I lift heavy loads 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
E) After working, I am tired 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
F) At work, I sweat 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
G) In comparison with others my own age, I think that my work is physically 
 
1) Much lighter          2) Lighter            3) As heavy         4) Heavier              5) Much heavier 
 
 
H) How many hours per week do you participate in any sports? 
 
1) Less than 1              2) 1-2             3) 2-3                 4) 3-4           5) Greater than 4 
 
 
I) In comparison to others my own age, I think that the amount of time I spend doing physical 
activity is 
 
1) Much less         2) Less            3) The same        4) More          5) Much more 
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J) During my leisure time, I sweat 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
K) During my leisure time, I watch television 
 
1) Always    2) Often        3) Sometimes       4) Seldom            5) Never    
 
 
L) During my leisure time, I walk 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
M)   During my leisure time, I cycle 
 
1) Never                2)  Seldom        3) Sometimes        4) Often            5) Always 
 
 
N) How many minutes per day do you walk and/or cycle? 
 
1) < 5    2) 5-15          3) 15-30         4) 30-45            5) > 45 
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APPENDIX C 
 
Medical History Questionnaire 
Navitas Cancer Rehabilitation Centers, LLC 
 
Please complete each section of this medical history questionnaire as thoroughly as 
possible.  If you are unsure of the answer to any question, please consult your physician.   
 
Name:        ID#:______________      Date: ___/___/____  
I.  Present Medical History 
Check all spaces that apply to you.  Include an explanation and the date of occurrence for 
checked items. 
 
Problem List     Explanation/Date  
 Abnormal EKG          
 Anemia           
 Arthritis           
 Asthma           
 Back/Neck pain/injury         
 Chest discomfort          
 Chronic/Recurring cough         
 Connective tissue disease         
 Coughing up blood         
 Dementia           
 Depression          
 Diabetes           
 Disease of arteries          
 Dizziness/Fainting         
 Epilepsy           
 Foot/Ankle problems         
 Heart problems          
 High cholesterol          
 High blood pressure         
 HIV/AIDS           
 Increased anxiety          
 Knee/Hip problems         
 Leg pain after walking         
 Liver disease (mild,mod.,severe)        
 Lung disease          
 Lymphedema          
 Migraine/recurrent headaches         
 Moderate or severe renal disease        
 Recurrent fatigue          
 Respiratory problems         
 Rheumatic fever          
 Sleeping problems         
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 Stroke           
 Stomach/Intestinal problems         
 Swollen/stiff/painful joints        
 Thyroid problems          
 Ulcer disease          
 Varicose veins          
 Deep Vein Thrombitis         
 Vision/hearing problems         
 
Females Only 
Current Menstrual Status:    In menarche   Menopausal    
 Pre-menopausal   Post-menopausal 
 Currently pregnant       ______ 
 Menstrual irregularities         
  
 Surgeries  
 Date:  Type:  
 Date:  Type:  
 Date:  Type:    
 Date:  Type:  
 
II. Family Medical History 
Please check the boxes that apply to family members that are genetically related to you 
(grandparents, mother, father, brothers, and sisters) 
        Problem List   
 Diabetes            
 Early death          
 Heart disease           
 High blood pressure         
 High cholesterol          
 Obesity           
 Stroke           
 Cancer(s) 
Type: ________________________ Family Member(s): _________________ 
Type: ________________________ Family Member(s): _________________ 
Type: ________________________ Family Member(s): _________________ 
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III. Medications List 
Please list ALL medications that you presently take.  Medications include prescription 
drugs, non-prescription drugs, vitamins, herbal supplements and hormone replacement 
therapy drugs. (If you need more space, bring in a written or typed list on a separate 
page) 
 
Medication: ________________________ Dosage/Frequency: _____________________ 
Medication: ________________________ Dosage/Frequency: _____________________ 
Medication: ________________________ Dosage/Frequency: _____________________ 
Medication: ________________________ Dosage/Frequency: _____________________ 
Medication: ________________________ Dosage/Frequency: _____________________ 
 
IV. Drug/Food/Environmental Allergies 
Please list any known substances that may cause you to have an allergic reaction. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
V.  Other Medical Concerns 
If you know of any other medical concerns that we should be made aware prior to your 
participation in this research study, please identify them below. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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APPENDIX D 
 
Cancer Treatment History Questionnaire 
Navitas Cancer Rehabilitation Centers, LLC 
 
Name:              ID#: _________     Date: ___/___/____ 
 
I.  Cancer Information 
Cancer Type/Location:           
Date of Diagnosis:     Stage/Grade at Diagnosis:    
 
Cancer Type/Location:          
Date of Diagnosis:     Stage/Grade at Diagnosis:    
  
II. Treatment Information 
 Surgery:  Yes Date: __________ Type:       
    No Date: __________ Type:       
   Date: __________ Type:        
 
 Chemotherapy:  
 
• Are you currently receiving chemotherapy?  
  YES 
  Do you have a chemotherapy port in place presently?     Yes  No  
 What chemotherapy drug(s) are you receiving?    
  ____________________________________________________________ 
  ____________________________________________________________ 
 
   Start date:  ____________  Next treatment:     
How many more treatments will you have?    
List any complications from treatment you are experiencing. 
          
 
  NO 
   Did you receive chemotherapy in the past?  Yes    No  
   Did you have a chemotherapy port?     Yes   No 
What chemotherapy drug(s) did you receive?  
       ____________ 
   ____________     
 
Start date:  ____________ Final treatment:  ____________ 
How many treatments did you have?  ____________ 
List any complications from treatment you have experienced. 
         
Will you be receiving chemo in the next 6 months?   Yes   No 
     
 
Radiation:  
        
• Are you currently receiving radiation? 
  YES 
   Start date:  ____________ Next treatment:  ____________ 
How many more treatments will you have? ___________ 
List any complications from treatment you are experiencing. 
          
 
  NO 
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   Did you receive radiation in the past?  Yes  No  
Start date:  ____________ Final treatment:  ____________ 
How many treatments did you have?  ____________ 
List any complications from treatment you have experienced. 
          
 
Will you be receiving radiation in the next 6 months?  Yes  No   
Biotherapy(BT): (Stem cell or bone marrow transplant, gene therapy, etc.) 
 Are you preparing/ have you begun to undergo any BT treatments? 
  YES 
   What type?          
Start date:  ____________  Next treatment:     
How many more treatments will you have?    
List any complications from treatment you are experiencing. 
          
 
  NO 
   Did you receive BTin the past?  Yes    No  
What type?           
Start date:  ____________ Final treatment:  ____________ 
What type did you receive?         
List any complications from treatment you experienced. 
          
Will you be receiving BT in the next 6 months?  Yes  No 
 
 Hormone Therapy(HT): 
Are you currently receiving HT? 
  YES 
   What type?          
Start date:  ____________  Next treatment:     
How many more treatments will you have?    
List any complications from treatment you are experiencing. 
          
 
  NO 
   Did you receive HT in the past?  Yes     No  
Start date:  ____________ Final treatment:  ____________ 
What type did you receive?         
List any complications from treatment you have experienced. 
          
Will you be receiving HT in the next 6 months?   Yes   No 
 
Alternative/Complimentary Therapy (ATC): 
Are you currently using any ATC? (Vitamins, herbs, supplements, etc.)  
  YES 
Start date:  ____________ Final treatment:  ____________ 
What type are you receiving?        
List any complications from treatment you have experienced. 
        ______ 
 
  NO 
   Did you use ATC in the past?   Yes  No  
Start date:  ____________ Final treatment:  ____________ 
What type did you receive?         
List any complications from treatment you experienced. 
          
Will you be receiving ATC in the next 6 months?    Yes   No 
 
Currently…  
Do you have any medical concerns due to your cancer/ cancer treatment(s)?  
 Yes       No   
If yes explain:    
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Do you have any physical limitations due to your cancer/ cancer treatment(s)?      
 Yes       No  
If yes explain:    
Do you use medications/ therapies to manage symptoms related to your cancer/treatment(s)?  
 Yes      No 
If yes explain:    
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